Insight
Patrick Hwu Highlighted Andrew Kuykendall’s Polycythemia Vera Study Featured in The Wall Street Journal
Patrick Hwu and Andrew Kuykendall

Patrick Hwu Highlighted Andrew Kuykendall’s Polycythemia Vera Study Featured in The Wall Street Journal

Patrick Hwu, President and CEO of the Moffitt Cancer Center, shared a post on X:

“Proud to see Andrew Kuykendall, Asst. Member in Malignant Hematology, Moffitt Cancer Center, leading this important study for patients with polycythemia vera.
His work, featured in The Wall Street Journal, offers new hope for patients with this rare blood cancer.”

Polycythemia Vera

More posts featuring Patrick Hwu on OncoDaily.

Andrew Kuykendall blood cancer Malignant Hematology Moffitt Cancer Center Patrick Hwu Polycythemia Vera rare blood cancer The Wall Street Journal